GT Biopharma Inc [NASDAQ: GTBP] jumped around 1.06 points on Monday, while shares priced at $2.81 at the close of the session, up 61.03%.
Compared to the average trading volume of 25.18K shares, GTBP reached a trading volume of 20787255 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
What do top market gurus say about GT Biopharma Inc [GTBP]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GTBP shares is $150.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GTBP stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ROTH MKM have made an estimate for GT Biopharma Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 02, 2024. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on May 24, 2021, representing the official price target for GT Biopharma Inc stock. Previously, the target price had yet another raise to $21, while B. Riley Securities analysts kept a Buy rating on GTBP stock.
The Average True Range (ATR) for GT Biopharma Inc is set at 0.48 The Price to Book ratio for the last quarter was 3.00, with the Price to Cash per share for the same quarter was set at 3.20.
How has GTBP stock performed recently?
GT Biopharma Inc [GTBP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 11.95. With this latest performance, GTBP shares dropped by -6.64% in over the last four-week period, additionally sinking by -4.75% over the last 6 months – not to mention a drop of -64.26% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GTBP stock in for the last two-week period is set at 53.48, with the RSI for the last a single of trading hit 56.74, and the three-weeks RSI is set at 52.31 for GT Biopharma Inc [GTBP]. The present Moving Average for the last 50 days of trading for this stock 2.7800, while it was recorded at 2.2000 for the last single week of trading, and 3.0000 for the last 200 days.
GT Biopharma Inc [GTBP]: Deeper insight into the fundamentals
GT Biopharma Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.45 and a Current Ratio set at 1.45.
Insider trade positions for GT Biopharma Inc [GTBP]
There are presently around $67.52%, or 76.85%% of GTBP stock, in the hands of institutional investors.
